Mirae Asset Global ETFs Holdings
NVCT icon

Mirae Asset Global ETFs Holdings’s Nuvectis Pharma NVCT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57K Buy
7,368
+170
+2% +$1.46K ﹤0.01% 2874
2025
Q4 		$54.3K Buy
7,198
+1,181
+20% +$7.7K ﹤0.01% 2911
2025
Q3 		$36.2K Sell
6,017
-1,012
-14% -$6.96K ﹤0.01% 2997
2025
Q2 		$52.5K Buy
+7,029
New +$63.7K ﹤0.01% 2873
2024
Q3 		– Sell
-3,254
Closed -$20.6K – 3150
2024
Q2 		$20.6K Buy
+3,254
New +$22.1K ﹤0.01% 2918

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NVCT Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Nuvectis Pharma (NVCT) stake by 2.4% in Q1 2026, buying an estimated $1.46K and bringing the position to 7,368 shares worth $57K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.

Mirae Asset Global ETFs Holdings first reported a position in NVCT in Q2 2024 and has held it in 5 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 7,368 shares of Nuvectis Pharma worth $57K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 170 Nuvectis Pharma shares in Q1 2026, an estimated $1.46K.
  • Nuvectis Pharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2874 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Nuvectis Pharma in Q2 2024 and has held it in 5 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.